InfuSystem Holdings, Inc. vs. Stryker Corporation
Stryker Corporation (SYK) comes out ahead, leading on 5 of 9 compared factors.
Size & Scale
| INFU | SYK | |
|---|---|---|
| Market Cap | $248.77 million | $129.43 billion |
| Revenue (TTM) | $143.34 million | $25.84 billion |
| Net Income (TTM) | $8.54 million | $3.73 billion |
SYK leads on 3 of 3 size & scale factors.
Valuation
| INFU | SYK | |
|---|---|---|
| P/E Ratio | 31.22 | 34.97 |
| Price / Book | 4.21 | 5.40 |
| Price / Sales | 1.74 | 5.01 |
INFU leads on 3 of 3 valuation factors.
Profitability
| INFU | SYK | |
|---|---|---|
| Net Margin | 5.96% | 14.43% |
| Return on Equity | 14.44% | 15.55% |
SYK leads on 2 of 2 profitability factors.
Dividend
| INFU | SYK | |
|---|---|---|
| Dividend Yield | — | 1.04% |
| Payout Ratio | — | 36.48 |
INFU and SYK split the dividend factors evenly.
Risk & Sentiment
| INFU | SYK | |
|---|---|---|
| Short Interest | 0.02% | 1.53% |
INFU leads on 1 of 1 risk & sentiment factors.
Dig deeper: INFU overview, INFU financials, SYK overview, SYK financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.